Dyronib 50mg Tablet is a prescription oncology medicine containing Dasatinib 50 mg, a targeted cancer therapy used in the treatment of blood cancers such as Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is particularly prescribed for patients when other treatments are ineffective or not tolerated. Dyronib works at the molecular level to slow or stop the growth of abnormal cancer cells, making it an important part of modern leukemia management under strict medical supervision.